Nathan Fowler

Clinical Professor

  • 5108 Citations
  • 33 h-Index
20082020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Nathan Fowler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 55 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A phase 1 trial of alisertib and romidepsin for relapsed/refractory aggressive B-cell and T-cell lymphomas

Strati, P., Nastoupil, L. J., Davis, R. E., Fayad, L. E., Fowler, N., Hagemeister, F. B., Kwak, L., Oki, Y., Wang, M., Westin, J., Ruben, C. E., Wesson, E. T., Piekarz, R., Fanale, M. A. & Lee, H. J., 2020, In : Haematologica. 105, 1, p. E26-E28

Research output: Contribution to journalLetter

Open Access
3 Scopus citations

De novo CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab era

Hu, B., Nastoupil, L. J., Loghavi, S., Westin, J. R., Thakral, B., Fayad, L. E., Hagemeister, F., Neelapu, S., Samaniego, F., Lee, H. J., Wang, M. L., Fanale, M. A., Fowler, N. & Oki, Y., Jan 28 2020, In : Leukemia and Lymphoma. 61, 2, p. 328-336 9 p.

Research output: Contribution to journalArticle

  • Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients

    Zhao, S., Kanagal-Shamanna, R., Navsaria, L., Ok, C. Y., Zhang, S., Nomie, K., Han, G., Hao, D., Hill, H. A., Jiang, C., Yao, Y., Nastoupil, L., Westin, J., Fayad, L., Nair, R., Steiner, R., Ahmed, S., Samaniego, F., Iyer, S. P., Oriabure, O. & 21 others, Chen, W., Song, X., Zhang, J., Badillo, M., Moghrabi, O., Aranda, J., Tang, G., Yin, C. C., Patel, K., Medeiros, L. J., Li, S., Vega, F., Thirumurthi, S., Xu, G., Neelapu, S., Flowers, C. R., Romaguera, J., Fowler, N., Wang, L., Wang, M. L. & Jain, P., Jun 1 2020, In : American journal of hematology. 95, 6, p. 623-629 7 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

    Jain, P., Zhang, S., Kanagal-Shamanna, R., Ok, C. Y., Nomie, K., Gonzalez, G. N., Gonzalez-Pagan, O., Hill, H. A., Lee, H. J., Fayad, L., Westin, J., Nastoupil, L., Hagemeister, F., Chen, W., Oriabure, O., Badillo, M., Jiang, C., Yixin, Y., Li, S., Tang, G. & 22 others, Yin, C. C., Patel, K. P., Medeiros, L. J., Nair, R., Ahmed, S., Iyer, S. P., Thirumurthi, S., Champlin, R., Xu, G., Tinsu, P., Santos, D., Wang, R., Han, G., Zhang, J., Song, X., Neelapu, S., Romaguera, J., Futreal, A., Flowers, C., Fowler, N., Wang, L. & Wang, M. L., Mar 24 2020, In : Blood Advances. 4, 6, p. 1038-1050 13 p.

    Research output: Contribution to journalArticle

    Open Access
  • 5 Scopus citations

    Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma

    Chin, C. K., Rodriguez, M. A., Qing, Y., Feng, L., Samaniego, F., Jain, P., Noorani, M., Fowler, N. H., Fayad, L. E., Westin, J. R., Neelapu, S. S., Hagemeister, F. B., Flowers, C. R. & Nastoupil, L., 2020, (Accepted/In press) In : Leukemia and Lymphoma.

    Research output: Contribution to journalLetter